Apyx Medical Corporation (APYX): Price and Financial Metrics
APYX Stock Summary
- APYX's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 1,129.56 -- higher than 96.04% of US-listed equities with positive expected earnings growth.
- The ratio of debt to operating expenses for Apyx Medical Corp is higher than it is for about merely 5.64% of US stocks.
- With a year-over-year growth in debt of -40.34%, Apyx Medical Corp's debt growth rate surpasses just 9.17% of about US stocks.
- Stocks with similar financial metrics, market capitalization, and price volatility to Apyx Medical Corp are ACRX, SIBN, ATEC, IGC, and CUTR.
- Visit APYX's SEC page to see the company's official filings. To visit the company's web site, go to apyxmedical.com.
APYX Stock Price Chart Interactive Chart >
APYX Price/Volume Stats
|Current price||$9.44||52-week high||$12.01|
|Prev. close||$9.38||52-week low||$2.81|
|Day high||$9.64||Avg. volume||98,909|
|50-day MA||$10.26||Dividend yield||N/A|
|200-day MA||$7.23||Market Cap||323.96M|
Apyx Medical Corporation (APYX) Company Bio
Apyx Medical Corporation, a energy technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue; and the J-Plasma system allows surgeons to operate in eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
APYX Latest News Stream
|Loading, please wait...|
APYX Latest Social Stream
View Full APYX Social Stream
Latest APYX News From Around the Web
Below are the latest news stories about Apyx Medical Corp that investors may wish to consider to help them evaluate APYX as an investment opportunity.
Apyx Medical Corporation (APYX) Q4 2020 Results Conference Call March 31, 2021 8:00 AM ET Company Participants Charlie Goodwin - President and Chief Executive Officer Tara Semb - Chief Financial Officer Conference Call Participants Matthew O'Brien - Piper Sandler Matt Hewitt - Craig-Hallum Kyle Bauser - Colliers Securities Russell Cleveland...
Apyx Medical Corp. reported a smaller-than-feared loss in the fourth quarter. Moreover, revenues topped analysts’ expectations. Shares of the advanced energy technology company rose 2.2% to close at $9.88 on March 30. Apyx Medical (APYX) incurred a loss of $0.04 per share in 4Q, compared to the $0.11 loss per share estimated by analysts. A loss of $0.16 per share was reported in the same quarter last year. Total revenues generated in the quarter increased 36.8% to $11.5 million and came in well ahead of the consensus estimate of $9.62 million. The company’s Advanced Energy segment sales jumped 44% year-over-year, while sales for the OEM segment grew 4%.
Apyx Medical Corporation ( NASDAQ:APYX ) shareholders have seen the share price descend 15% over the month. But that...
Apyx (APYX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 11) Affimed N.V. (NASDAQ: AFMD ) AngioDynamics, Inc. (NASDAQ: ANGO ) Apyx Medical Corporation (NASDAQ: APYX ) AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO ) Axonics Modulation Technologies, Inc. (NASDAQ: AXNX ) BioAtla, Inc. (NASDAQ: BCAB ) BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX ) Bolt Biotherapeutics, Inc. (NASDAQ: BOLT ) Entera Bio Ltd. (NASDAQ: ENTX ) ( announced positive Phase 2 biomarker data for osteoarthritis drug) Harvard Bioscience, Inc. (NASDAQ: HBIO ) IDEAYA Biosciences, Inc. (NASDAQ: IDYA ) Inari Medical, Inc. (NASDAQ: NARI ) Jounce Therapeutics, Inc. (NASDAQ: JNCE ) Longeveron Inc. (NASDAQ: LGVN ) (announced FDA granting expanded ...
APYX Price Returns
Continue Researching APYXWant to do more research on Apyx Medical Corp's stock and its price? Try the links below:
Get Free Updates
Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!